---
date: '2025-05-08'
modified_time: 2025-05-08 10:45:46-04:00
published_time: 2025-05-08 10:45:30-04:00
source_url: https://www.whitehouse.gov/articles/2025/05/president-trump-is-bringing-drug-manufacturing-back/
tags: articles
title: President Trump is Bringing Drug Manufacturing Back
---
 
President Donald J. Trump is determined to make the American
pharmaceutical and biotechnology industries great again — both as a
matter of national security and to unleash unprecedented prosperity for
American workers.  
  
Gilead Sciences became the latest industry leader to announce a massive
new investment in its U.S. operations with an [$11 billion
boost](https://www.reuters.com/business/healthcare-pharmaceuticals/gilead-announces-11-billion-new-investments-us-2025-05-07/)
to its planned U.S.-based spending.  
  
**The company joins a host of others in expanding their domestic
footprint to align with President Trump’s vision:**

-   New Jersey-based **Johnson &
    Johnson** [announced](https://www.jnj.com/media-center/press-releases/johnson-johnson-increases-u-s-investment-to-more-than-55-billion-over-the-next-four-years) a
    $55 billion investment in manufacturing, research and development,
    and technology.
-   **Roche**, a Swiss drug and diagnostics
    company, [announced](https://www.roche.com/investors/updates/inv-update-2025-04-22) a
    $50 billion investment in its U.S.-based manufacturing and research
    and development.
-   New Jersey-based **Bristol Myers Squibb**
    [announced](https://www.bloomberg.com/news/articles/2025-05-05/bristol-myers-promises-40-billion-us-investment-over-five-years)
    a $40 billion investment in research, development, technology, and
    manufacturing.
-   Indiana-based **Eli Lilly and
    Company** [announced](https://investor.lilly.com/news-releases/news-release-details/lilly-plans-more-double-us-manufacturing-investment-2020) a
    $27 billion investment to more than double its domestic
    manufacturing capacity.
-   **Novartis**, a Swiss
    drugmaker, [announced](https://www.novartis.com/us-en/news/media-releases/novartis-plans-expand-its-us-based-manufacturing-and-rd-footprint-total-investment-23b-over-next-5-years) a $23
    billion investment to build or expand ten manufacturing facilities
    across the U.S.
-   Illinois-based **AbbVie**
    [announced](https://www.pharmamanufacturing.com/all-articles/article/55286102/abbvie-plans-10b-investment-in-us-manufacturing-over-the-next-decade)
    a $10 billion investment over the next ten years to support volume
    growth and add four new manufacturing plants to its network.
-   New Jersey-based **Merck &
    Co.** [announced](https://www.merck.com/news/merck-unveils-new-facility-to-increase-vaccine-production-capacity/) it
    will invest a total of $9 billion over the next several years after
    opening a new $1 billion North Carolina manufacturing facility —
    [including](https://www.merck.com/news/merck-breaks-ground-on-new-1-billion-biologics-center-of-excellence-in-wilmington-delaware/)
    a new state-of-the-art biologics manufacturing plant in Delaware.
    -   **Merck Animal Health**
        [announced](https://www.reuters.com/business/healthcare-pharmaceuticals/merck-animal-health-announces-895-million-investment-kansas-2025-05-08/)
        an $895 million investment to expand their manufacturing
        operation in Kansas.
-   New York-based **Regeneron Pharmaceuticals**
    [announced](https://newsroom.regeneron.com/news-releases/news-release-details/regeneron-announces-new-investment-manufacturing-its-industry)
    a $3 billion agreement with FUJIFILM Diosynth Biotechnologies to
    produce drugs at its North Carolina facility.
-   California-based **Amgen**
    [announced](https://www.amgen.com/newsroom/press-releases/2025/04/amgen-announces-900-million-manufacturing-expansion-creation-of-350-new-jobs-in-ohio)
    a $900 million investment in its Ohio-based manufacturing operation.
-   Illinois-based **Abbott
    Laboratories** [announced](https://www.bloomberg.com/news/articles/2025-04-16/abbott-to-build-new-us-manufacturing-with-tariff-threat-looming) a
    $500 million investment in its Illinois and Texas facilities.
